Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors

被引:36
作者
Addeo, R
Altucci, L
Battista, T
Bonapace, IM
Cancemi, M
Cicatiello, L
Germano, D
Pacilio, C
Salzano, S
Bresciani, F
Weisz, A
机构
[1] UNIV NAPLES 2,FAC MED & CHIRURG,IST PATOL GEN & ONCOL,I-80138 NAPLES,ITALY
[2] UNIV NAPLES FEDERICO II,DIPARTIMENTO BIOL & PATOL CELLULARE & MOLEC L CAL,NAPLES,ITALY
关键词
D O I
10.1006/bbrc.1996.0494
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitors of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase, such as Simvastatin and Lovastatin, reduce the rate of DNA synthesis and proliferation of a wide variety of cell types in vitro, by inducing a cell cycle arrest in G(1). In estrogen-free medium, DNA synthesis is reduced by more that 90% following exposure of normal and transformed human boast epithelial cells to 20 mu M Simvastatin or Lovastatin for 24 to 42hrs. We show here that stimulation of estrogen responsive MCF-7 cells with nanomolar concentrations of 17 beta-estradiol (E2) prevents inhibition of DNA synthesis by these compounds. The effect of the hormone is antagonized by both steroidal and non steroidal antiestrogens, and it is not detectable in estrogen receptor-negative MCF-10a cells. Cell cycle analysis demonstrates that HMG-CoA reductase inhibitors are unable to induce G(1) arrest of MCF-7 cells in the presence of E2. (C) 1996 Academic Press, Inc.
引用
收藏
页码:864 / 870
页数:7
相关论文
共 24 条
[1]  
ALTUCCI L, 1996, IN PRESS ONCOGENE, V13
[2]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[3]  
BONAPACE JM, 1996, IN PRESS ONCOGENE, V12
[4]  
CICATIELLO L, 1993, RECEPTOR, V3, P17
[5]   TRANSCRIPTIONAL ACTIVATION OF JUN AND ACTIN GENES BY ESTROGEN DURING MITOGENIC STIMULATION OF RAT UTERINE CELLS [J].
CICATIELLO, L ;
AMBROSINO, C ;
COLETTA, B ;
SCALONA, M ;
SICA, V ;
BRESCIANI, F ;
WEISZ, A .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :523-528
[6]  
DAVIDSON NE, 1989, ONCOGENESIS, V1, P89
[7]  
DUBIK D, 1992, ONCOGENE, V7, P1587
[8]   FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J].
GIBBS, JB ;
OLIFF, A ;
KOHL, NE .
CELL, 1994, 77 (02) :175-178
[9]   THE PROTOONCOGENE C-JUN CONTAINS AN UNUSUAL ESTROGEN-INDUCIBLE ENHANCER WITHIN THE CODING SEQUENCE [J].
HYDER, SM ;
NAWAZ, Z ;
CHIAPPETTA, C ;
YOKOYAMA, K ;
STANCEL, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8506-8513
[10]  
HYDER SM, 1992, J BIOL CHEM, V267, P18047